STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Penumbra, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Penumbra, Inc. (PEN) Form 144 notice: An affiliated person proposes to sell 15,800 shares of common stock through Morgan Stanley Smith Barney on 09/03/2025. The shares were acquired the same day by stock option exercise and paid in cash. The filing reports an aggregate market value of $4,260,403.64 for the proposed sale and lists 38,999,129 shares outstanding for the issuer. The notice also discloses six prior open-market sales by the same person between 06/11/2025 and 08/20/2025, totaling 95,865 shares sold in the past three months, with separate gross proceeds reported for each trade. The filer attests there is no undisclosed material adverse information.

Positive
  • Complete disclosure of broker, acquisition method (stock option exercise), sale date, and aggregate market value
  • Itemized prior sales in the past three months provide transparent historical trading activity by the seller
Negative
  • Multiple recent insider sales totaling 95,865 shares in the past three months, which may attract investor attention even though quantity is small relative to shares outstanding
  • No 10b5-1 plan date provided in the form, so the filing does not indicate a prior written trading plan

Insights

TL;DR: Routine insider exercise and planned sale, with multiple recent dispositions but small relative to total shares outstanding.

The filing records an insider stock option exercise followed by a proposed sale of 15,800 shares on 09/03/2025, executed through Morgan Stanley Smith Barney. The filing transparently discloses past transactions: six open-market sales totaling 95,865 shares across June–August 2025. Relative to the issuer's reported 38,999,129 shares outstanding, the cumulative recent sales represent a small fraction of outstanding equity, indicating limited direct dilution or immediate market-impact risk. This is a standard Rule 144 disclosure and does not include operational or financial results.

TL;DR: Compliance-focused disclosure showing adherence to Rule 144 procedures; no governance red flags in the notice itself.

The document furnishes required seller identity, broker details, acquisition date and nature (stock option exercise), and confirmation of absence of undisclosed material information. The repeated sales over the prior three months are fully itemized with dates and gross proceeds, which supports transparency. The filing contains no claims about trading plans or 10b5-1 adoption dates; absence of such a plan is explicitly noted by lack of a plan date in the form fields.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

Who is proposing to sell shares according to the Form 144 for PEN?

The filing identifies the seller as Adam Elsesser with an address listed; the proposed sale is for his account.

How many shares does the Form 144 propose to sell on 09/03/2025 for PEN?

The notice proposes the sale of 15,800 shares of common stock on 09/03/2025 through Morgan Stanley Smith Barney.

How were the 15,800 PEN shares acquired?

The shares were acquired on 09/03/2025 by a stock option exercise and payment was made in cash.

What prior insider sales are disclosed in the Form 144 for PEN?

The filing lists six prior sales between 06/11/2025 and 08/20/2025, totaling 95,865 shares with gross proceeds reported for each trade.

What is the aggregate market value reported for the proposed PEN sale?

The filing reports an aggregate market value of $4,260,403.64 for the 15,800 shares to be sold.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

10.96B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA